Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019
James A. Karlowskya, Krystyna M. Kazmierczakb,
Corresponding author
kkazmierczak@ihmainc.com

Corresponding author.
, Maria Lavínea Novis de Figueiredo Valentec, Elkin Lemos Luengasd, Monique Baudrite, Alvaro Quintanaf, Paurus Iranig, Gregory G. Stoneh, Daniel F. Sahmb
a University of Manitoba, Max Rady College of Medicine, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Canada
b IHMA, Schaumburg, IL, USA
c Pfizer Brazil, São Paulo, SP, Brazil
d Pfizer Colombia, Bogota, Colombia
e Pfizer Central America and Caribbean, Cartago, Costa Rica
f Pfizer Inc., New York, NY, USA
g Pfizer UK ltd, Walton Oaks, Tadworth, Surrey, UK
h Pfizer Inc., Groton, CT, USA
Read
2602
Times
was read the article
1112
Total PDF
1490
Total HTML
Share statistics
Article information
ISSN: 14138670
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 24 16 40
2024 March 48 29 77
2024 February 35 22 57
2024 January 44 36 80
2023 December 35 37 72
2023 November 34 45 79
2023 October 25 38 63
2023 September 41 61 102
2023 August 17 23 40
2023 July 33 24 57
2023 June 41 16 57
2023 May 40 18 58
2023 April 37 22 59
2023 March 71 30 101
2023 February 60 26 86
2023 January 29 31 60
2022 December 61 40 101
2022 November 69 34 103
2022 October 57 28 85
2022 September 44 70 114
2022 August 35 44 79
2022 July 61 49 110
2022 June 67 56 123
2022 May 50 26 76
2022 April 77 41 118
2022 March 87 59 146
2022 February 105 50 155
2022 January 73 49 122
2021 December 67 62 129
2021 November 23 30 53
Show all

Follow this link to access the full text of the article

The Brazilian Journal of Infectious Diseases